{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:58:35Z","timestamp":1777867115807,"version":"3.51.4"},"reference-count":0,"publisher":"S. Karger AG","license":[{"start":{"date-parts":[[2009,10,16]],"date-time":"2009-10-16T00:00:00Z","timestamp":1255651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"},{"start":{"date-parts":[[2009,10,16]],"date-time":"2009-10-16T00:00:00Z","timestamp":1255651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologica"],"abstract":"<jats:p>Beta-adrenergic blocking agents have a significant corticosteroid-sparing effect in the treatment of pemphigus vulgaris. In 18 patients, observations over a period of 8-27 months have shown that, in terms of percentage of the maintenance dose of betamethasone when administered alone, the corticosteroid-sparing effect of propranolol 120 mg was 33.3\u201383.3% in 17 patients and 100% in 1 patient. It is postulated that propranolol affects the vasodilator fibres as a result of which the influx of plasma in blisterformation is prevented or minimised.<\/jats:p>","DOI":"10.1159\/000251946","type":"journal-article","created":{"date-parts":[[2009,11,10]],"date-time":"2009-11-10T10:03:59Z","timestamp":1257847439000},"page":"55-60","source":"Crossref","is-referenced-by-count":2,"title":["Corticosteroid-Sparing Effect of \u03b2-Adrenergic Blocking Agents in Pemphigus vulgaris"],"prefix":"10.1159","author":[{"given":"I.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.N.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.N.","family":"Seth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"Gaind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2009,10,16]]},"container-title":["Dermatologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/251946","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/karger.com\/article-pdf\/doi\/10.1159\/000251946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:50:44Z","timestamp":1777542644000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000251946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,16]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1159\/000251946","archive":["Portico"],"relation":{},"ISSN":["0011-9075","2571-7197"],"issn-type":[{"value":"0011-9075","type":"print"},{"value":"2571-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,16]]}}}